Longitudinal changes in the brain in mild cognitive impairment: a magnetic resonance imaging study using the visual rating method and tensor-based morphometry

Abstract

Background

Brain atrophy is associated with mild cognitive impairment (MCI), and by using volumetric and visual analyzing methods, it is possible to differentiate between individuals with progressive MCI (MCIp) and stable MCI (MCIs). Automated analysis methods detect degenerative changes in the brain earlier and more reliably than visual methods.

Purpose

To detect and evaluate structural brain changes between and within the MCIs, MCIp, and control groups during a two-year follow-up period.

Material and Methods

Brain magnetic resonance imaging (MRI) scans of 11 participants with MCIs, 18 participants with MCIp, and 84 controls were analyzed by the visual rating method (VRM) and tensor-based morphometry (TBM).

Results

At baseline, both VRM and TBM differentiated the whole MCI group (combined MCIs and MCIp) and the MCIp group from the control group, but they did not differentiate the MCIs group from the control group. At follow-up, both methods differentiated the MCIp group from the control group, but minor differences between the MCIs and control groups were only seen by TBM. Neuropsychological tests did not find differences between the MCIs and control groups at follow-up. Neither method revealed relevant signs of brain atrophy progression within or between MCI subgroups during the follow-up time.

Conclusion

Both methods are equally good in the evaluation of structural brain changes in MCI if the groups are sufficiently large and the disease progresses to AD. Only TBM disclosed minor atrophic changes in the MCIs group compared to controls at follow-up. The results need to be confirmed with a large patient group and longer follow-up time.

Keywords

Visual rating tensor-based morphometry Alzheimer’s disease mild cognitive impairment magnetic resonance imaging (MRI)dementia

Get full access to this article

View all access options for this article.

References

Lockhart

DeCarli

. Structural imaging measures of brain aging. Neuropsychol Rev 2014; 24: 271–289.

Driscoll

Davatzikos

et al.

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 2009; 72: 1906–1913.

Chou

Lepore

Saharan

et al.

Ventricular maps in 804 ADNI subjects: Correlations with CSF biomarkers and clinical decline. Neurobiol Aging 2010; 31: 1386–1400.

McDonald

Gharapetian

McEvoy

et al.

Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging 2012; 33: 242–253.

Tondelli

Wilcock

Nichelli

et al.

Structural MRI changes detectable up to ten years before clinical Alzheimer’s disease. Neurobiol Aging 2012; 33: 825.e25–e36.

Bozzali

Filippi

Magnani

et al.

The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 2006; 67: 453–460.

Chetelat

Landeau

Eustache

et al.

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 2005; 27: 934–946.

Dubois

Feldman

Jacova

et al.

Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734–746.

Frisoni

Fox

Jack

Jr et al.

The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010; 6: 67–77.

10.

Hamalainen

Tervo

Grau-Olivares

et al.

Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 2007; 37: 1122–1131.

11.

Devanand

Bansal

Liu

et al.

MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer’s disease. Neuroimage 2012; 60: 1622–1629.

12.

Braskie

Thompson

. A focus on structural brain imaging in the Alzheimer’s disease neuroimaging initiative. Biol Psychiatry 2014; 75: 527–533.

13.

Jacobs

Van Boxtel

Uylings

et al.

Atrophy of the parietal lobe in preclinical dementia. Brain Cogn 2011; 75: 154–163.

14.

Cardenas

Chao

Studholme

et al.

Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging 2011; 32: 572–580.

15.

Lindberg

Westman

Karlsson

et al.

Is the subcallosal medial prefrontal cortex a common site of atrophy in Alzheimer’s disease and frontotemporal lobar degeneration?

Front Aging Neurosci 2012; 4: 1–8.

16.

Duara

Loewenstein

Potter

et al.

Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008; 71: 1986–1992.

17.

Scheltens

Leys

Barkhof

et al.

Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967–972.

18.

Ashburner

Hutton

Frackowiak

et al.

Identifying global anatomical differences: Deformation-based morphometry. Hum Brain Mapp 1998; 6: 348–357.

19.

Hua

Leow

Lee

et al.

3D characterization of brain atrophy in Alzheimer’s disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008; 41: 19–34.

20.

Hua

Lee

Hibar

et al.

Mapping Alzheimer’s disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals. Neuroimage 2010; 51: 63–75.

21.

Leow

Yanovsky

Parikshak

et al.

Alzheimer’s disease neuroimaging initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 2009; 45: 645–655.

22.

Tuokkola

Koikkalainen

Parkkola

et al.

Visual rating method and tensor-based morphometry in the diagnosis of mild cognitive impairment and Alzheimer’s disease: A comparative magnetic resonance imaging study. Acta Radiol 2016; 57: 348–355.

23.

Petersen

Stevens

Ganguli

et al.

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133–1142.

24.

Morris

Heyman

Mohs

et al.

The consortium to establish a registry for Alzheimer’s disease (CERAD). part I. clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989; 39: 1159–1165.

25.

Wechsler DA, editor. Wechsler Memory Scale-Revised: Manual. San Antonio, TX: The Psychological Corporation & Harcourt Brace Jovanovich, Inc, 1987.

26.

Reitan

. A Manual for the Administration and Scoring of the Trail Making Test , Bloomington, IN: Indiana University Press, 1959.

27.

Victoroff

Mack

Grafton

et al.

A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology 1994; 44: 2267–2276.

28.

Heckemann

Hajnal

Aljabar

et al.

Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage 2006; 33: 115–126.

29.

Koikkalainen

Lotjonen

Thurfjell

et al.

Multi-template tensor-based morphometry: Application to analysis of Alzheimer’s disease. Neuroimage 2011; 56: 1134–1144.

30.

Scheltens

Launer

Barkhof

et al.

Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability. J Neurol 1995; 242: 557–560.